Cyr61 mediates oxaliplatin resistance in colorectal cancer cells by regulating Bcl-xL expression

Although the clinical application of oxaliplatin (L-OHP) has improved the survival of colorectal cancer (CRC) patients, approximately half of patients with CRC fail to achieve good clinical outcomes, indicating resistance to L-OHP therapy. Cysteine-rich protein 61 (Cyr61), a multifunctional extracel...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cancer
Hlavní autoři: Song, Yanfang, Kang, Yanli, Lin, Zhen, Zeng, Menglu, Shi, Pengchong, Lin, Jia, Lu, Pingxia, Luo, Li, Cao, Yingping, Zhu, Xianjin
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2021
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7974528/
https://ncbi.nlm.nih.gov/pubmed/33753993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.48891
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky